Creative Biolabs-Immuno-oncology

Anti-CLDN6 (clone h2E7J.1G0Z8P) SynExpress C-Cy5-β-B Modified CD8+ T cells (CAT#: ITS-1224-CR1919)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLDN6 (clone h2E7J.1G0Z8P). We employs the Lentivirus (CMV-Cy5-β-catenin-BamHI) vector components and the SynExpress system of the Multiple base pair Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CLDN6
Clone
h2E7J.1G0Z8P
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy5
Promoter
CMV
Effector Gene
β-catenin
Insertion Sites
BamHI
Gene Modification
Knockout
Modification Domain
Multiple base pair
Carrier Type
Lentivirus
Transformation Accuracy
0.98
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving